Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014, 158(4):577-582 | DOI: 10.5507/bp.2013.008

Long term visual outcome after arteriolar constriction in patients with branch retinal vein occlusion

Jiri Rehaka, Ladislav Dusekb, Martin Sina, Barbora Babkovaa, Zuzana Pracharovaa, Matus Rehaka,c
a Department of Ophthalmology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic
b Institute of Biostatistics and Analyses, Masaryk University, Brno
c Department of Ophthalmology, University of Leipzig, Leipzig, Germany

Aim: To evaluate the final best corrected visual acuity (BCVA) in patients with branch retinal vein occlusion (BRVO) treated with either (1) laser arteriolar constriction (ACo) or (2) the standard treatment recommended by the Branch Vein Occlusion Study Group (grid laser photocoagulation (GLP) or only observation (if indication criteria for GLP were not met).

Methods: 358 BRVOs were treated in three different ways: early ACo (n=133) performed ≤ 9 weeks after onset of BRVO, late ACo (n=62) performed > 9 weeks after onset and controls which included GLP and observation (n=163). The groups were further divided according to initial BCVA into: ≤ 0.1; 0.16-0.3 and ≥ 0.4.

Results: Based on the proportion of 1 year BCVA ≤ 0.1 as a risk category, the results of early ACo (3.8%) were significantly better than for the controls (22.7%, P<0.001) and late ACo (16.1%, P=0.006). The greatest difference in final BCVA was in patients with the worst initial VA (≤ 0.1). In the intermediate initial BCVA group 0.16-0.3, a significant difference was only found between the early ACo group and controls (P=0.007). There was no significant difference between any treatment group and prevalence of a final BCVA ≤ 0.1 for patients with an initial BCVA ≥ 0.4.

Conclusions: Early ACo significantly reduces the prevalence of a final BCVA ≤ 0.1 in patients with BRVO and an initial BCVA ≤ 0.3 compared to controls (standard treatment treated with GLP or observed).

Keywords: branch retinal vein occlusion, grid laser photocoagulation, arteriolar constriction, visual acuity, predictive factors

Received: October 3, 2012; Accepted: January 18, 2013; Prepublished online: March 25, 2013; Published: December 9, 2014  Show citation

ACS AIP APA ASA Harvard Chicago IEEE ISO690 MLA NLM Turabian Vancouver
Rehak, J., Dusek, L., Sin, M., Babkova, B., Pracharova, Z., & Rehak, M. (2014). Long term visual outcome after arteriolar constriction in patients with branch retinal vein occlusion. Biomedical papers, 158(4), 577-582. doi: 10.5507/bp.2013.008
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Rehak J, Rehak M. Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities. Curr Eye Res 2008;33(2):111-31. Go to original source... Go to PubMed...
    2. Gutman FA, Zegarra H, Zakov ZN. The natural course of temporal retinal vein occlusion. Trans Am Acad Opthalmol Otolaryngol 1974;78(2):178-92.
    3. Jalkh AE, Avila PM, Zakka KA, Trempe CL, Schepens CL. Chronic macular edema in retinal branch vein occlusion: Role of laser photocoagulation. Annals Ophthalmol 1984;16(6):526-9.
    4. Morse PH. Prospective rationale for and results of argon laser treatment of patients with branch retinal vein occlusion. Annals Ophthalmol 1985;17(9):565-71.
    5. Karagiannis DA, Karampelas MD, Soumplis VM, Amariotakis C, Georgalas I, Kandarakis A. Recurrence of macular edema in retinal vein occlusions after treatment with intravitreal ranibizumab (Lucentis). Can J Ophthalmol 2011;46(6):486-90. Go to original source... Go to PubMed...
    6. Brown DM, Campochiaro PA, Bhisitkul RB, Ho AC, Gray S, Saroj N, Adami AP, Rubio RG, Murahashi WY. Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study. Ophthalmology 2011;118(8):1594-602. Go to original source... Go to PubMed...
    7. Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jiao J, Li X-Y, Whitcup SM. Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results. Ophthalmology 2011;118(12):2453-60. Go to original source... Go to PubMed...
    8. Jaissle GB, Leitritz M, Gelisken F, Ziemssen F, Bartz-Schmidt KU, Szurman P. One-year results after intravitreal bevacizumab therapy for macular edema secondary to branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2009;247(1):27-33. Go to original source... Go to PubMed...
    9. The SCORE Study Research Group. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the standard care vs corticosteroid for retinal vein occlusion (SCORE) study report 6. Arch Ophthalmol 2009;27(9):1115-28. Go to original source...
    10. Campochiaro PA, Heier JS, Feiner L, Gray S, Saroj N, Rundle AC, Murahashi WY, Rubio RG: Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology 2010;117(6):1102-12. Go to original source... Go to PubMed...
    11. L'Esperance FA: Ocular photocoagulation. A stereoscopic atlas. St.Louis, CV Mosby Company,1975, pp 215-22.
    12. Rehak J, Vymazal M. Arteriolar constriction in the treatment of occlusion of the retinal branch of the vein.Our first experiences.(in Czech) Cesk Oftalmol. 1993;49(3):155-9.
    13. Rehak J. Branch retinal vein occlusion: Early laser treatment. New approach. XIth.Congress of the European Society of Ophthalmology, Budapest, Hungary 1997;2:1157-60.
    14. Rehak J: Branch retinal vein occlusion. Part 2. Early Treatment with Argon Laser. New Approach. New Trends Ophthalmol 1997;12:77-82.
    15. Erdöl H, Akyol N. Arterial crimping in branch retinal vein occlusion with macular edema. Acta Ophthalmol Scand 2000;78(4):456-9. Go to original source... Go to PubMed...
    16. Branch Vein Occlusion Study Group. Argon laser photocoagulation for macular edema in branch retinal vein occlusion. Am J Ophthalmol 1984;98(3):271-82. Go to original source... Go to PubMed...
    17. Branch Vein Occlusion Study Group. Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. Arch Ophthalmol 1986;104(1):34-41. Go to original source... Go to PubMed...
    18. Eng J. ROC analysis: web-based calculator for ROC curves. Baltimore, Johns Hopkins University [updated 2006 May 17; cited 2008 February 20]. Available from: http://www.jrocfit.org.
    19. Rehak J, Dusek L, Chrapek O, Fric E, Rehak M. Initial visual acuity is an important prognostic factor in patients with branch retinal vein occlusion. Opthalmic Res 2011;45(4):204-9. Go to original source... Go to PubMed...
    20. Finkelstein D. Argon laser photocoagulation for macular edema in branch retinal vein occlusion. Ophthalmology 1986;93(7):975-7. Go to original source... Go to PubMed...
    21. Roseman RL, Olk RJ. Krypton red laser photocoagulation for branch retinal vein occlusion. Ophthalmology 1987;94(9):1120-5. Go to original source... Go to PubMed...
    22. Jaissle GB, Szurman P, Feltgen N, Spitzer B, Pielen A, Rehak M, Spital G, Heimann H, Meyer CH. Predictive factors for functional improvement after intravitreal bevacizumab for macular edema due to branch retinal vein occlusion. Graefes Arch Clin. Exp. Ophthalmol. 2011;249(2):183-92. Go to original source... Go to PubMed...

    Return to the content